High-rate pulmonary involvement in autoimmune pancreatitis
Article first published online: 22 DEC 2005
Internal Medicine Journal
Volume 36, Issue 1, pages 58–61, January 2006
How to Cite
Hirano, K., Kawabe, T., Komatsu, Y., Matsubara, S., Togawa, O., Arizumi, T., Yamamoto, N., Nakai, Y., Sasahira, N., Tsujino, T., Toda, N., Isayama, H., Tada, M. and Omata, M. (2006), High-rate pulmonary involvement in autoimmune pancreatitis. Internal Medicine Journal, 36: 58–61. doi: 10.1111/j.1445-5994.2006.01009.x
Potential conflicts of interest: None
- Issue published online: 22 DEC 2005
- Article first published online: 22 DEC 2005
- Received 31 March 2005; accepted 23 September 2005.
- autoimmune pancreatitis;
- interstitial pneumonia;
Autoimmune pancreatitis (AIP) has extrapancreatic complications such as Sjögren's syndrome, retroperitoneal fibrosis and sclerosing cholangitis. We studied 30 patients with AIP. Of these, we identified pulmonary involvement in four patients during follow up. Among them, two patients had respiratory failure. They showed good response to steroid therapy, but a higher dose of prednisolone was necessary to maintain remission than that required in biliary involvement. Elevation of immunoglobulin G4 and Krebs von den Lungen-6 levels were characteristic of pulmonary involvement. They may be useful for early detection of pulmonary complication.